Clinical trial
An Observational Study to Assess Persistence, Adherence, Quality of Life, and Treatment Satisfaction in Patients Beginning Therapy With the Avonex® PEN™.
NCT01405872 is registered in ClinicalTrials.gov with Biogen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study to Assess Persistence, Adherence, Quality of Life, and Treatment Satisfaction in Patients Beginning Therapy With the Avonex® PEN™.
- Lead sponsor
- Biogen
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2011
- Completion date
- September 30, 2013
- Enrollment
- 270 (actual)
- Sites
- 64
Conditions
As the registry lists them; a condition with its own page is linked.